Adi Mohanty Joins Michael D. West, PhD, as Co-CEO of BioTime, Inc.

BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, reported today that its Board of Directors has appointed Adi Mohanty to serve with Michael D. West, PhD, as co-Chief Executive Officer. Mr. Mohanty has served as BioTime’s Chief Operating Officer since December 2014. Dr. West will lead BioTime’s science, technology development, and intellectual property activities with a particular focus on growing the company’s discovery and pre-clinical product development programs. Mr. Mohanty will lead the company’s advanced clinical development programs and commercialization strategies,...